Attached files

file filename
10-K - FORM 10-K - Rezolute, Inc.v420245_10k.htm
EX-21.1 - EXHIBIT 21.1 - Rezolute, Inc.v420245_ex21-1.htm
EX-31.1 - EXHIBIT 31.1 - Rezolute, Inc.v420245_ex31-1.htm
EX-32.2 - EXHIBIT 32.2 - Rezolute, Inc.v420245_ex32-2.htm
EX-31.2 - EXHIBIT 31.2 - Rezolute, Inc.v420245_ex31-2.htm






Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. Section 1350), Nevan Elam, Chief Executive Officer of AntriaBio, Inc. (the “Company”), hereby certifies that, to the best of his knowledge:


  1. The Company’s annual report on Form 10-K for the fiscal year ended June 30, 2015, to which this Certification is attached as Exhibit 32.1 (the “Periodic Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and


  2. The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


In witness whereof, the undersigned have set their hands hereto as of the 28th of September 2015.


/s/    Nevan Elam  

Nevan Elam

Chief Executive Officer




(1)  This certification accompanies the annual report on Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of AntriaBio, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing. A signed original of this written statement required by section 906 of the Sarbanes-Oxley Act of 2002 has been provided to AntriaBio, Inc. and will be retained by AntriaBio, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.